#167: Dr. James Todaro

— Dr. James Todaro's research on hydroxychloroquine as a potential COVID-19 treatment and the media backlash he experienced for publishing early findings.

— The fraudulent Lancet study (May 2020) claiming hydroxychloroquine increased mortality, retracted after investigation revealed fabricated data from Surgisphere.

— Surgisphere's deception: a shell company with minimal staff, fake credentials, hidden web history, and an adult model posing as a director, used to validate flawed research.

— Conflicts of interest between the World Health Organization, CDC, Big Pharma (especially Gilead with competing drug remdesivir), and prominent health officials suppressing generic hydroxychloroquine.

— Aggressive censorship of dissenting medical voices by Google, YouTube, Facebook, and Amazon, including removal of Todaro's research doc and suppression of the Bakersfield doctors' video.

— Perverse incentives in the medical industry, vaccine development timelines, and the need for institutional reform to resist censorship and restore trust in research.

— Verify information independently across multiple sources rather than trusting institutional pronouncements; the Twitter community often fact-checks faster than traditional peer review when financial or political incentives are at play.

— Monitor long-term monetary expansion and central bank policy as drivers of Bitcoin adoption; Todaro expects "phenomenal" Bitcoin performance over the next two to three years as money-printing accelerates.

— Stay aware of how censorship of dissenting medical research parallels censorship of Bitcoin commentary; loss of platform access effectively silences minority opinions regardless of merit, particularly as social media dominates information distribution.